New 1H-Benzo[f]indazole-4,9-diones Conjugated with C-Protected Amino Acids and Other Derivatives: Synthesis and in Vitro Antiproliferative Evaluation

被引:8
作者
Molinari, Aurora [1 ]
Oliva, Alfonso [1 ]
Arismendi-Macuer, Marlene [1 ]
Guzman, Leda [1 ]
Fuentealba, Mauricio [1 ]
Knox, Marcela [1 ]
Vinet, Raul [2 ,3 ]
San Feliciano, Arturo [4 ]
机构
[1] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Quim, Valparaiso 2373223, Chile
[2] Univ Valparaiso, Fac Farm, Valparaiso 2360102, Chile
[3] CREAS, Valparaiso 2362696, Chile
[4] Univ Salamanca, Fac Farm, Dept Quim Farmaceut, CIETUS,IBSAL, E-37007 Salamanca, Spain
关键词
1; 4-naphthoquinone; 1H-benzoindazole; pyrazole; amino acid; TUMOR-CELL LINES; NUMERICAL-INTEGRATION; SORAFENIB; QUINONES; CYTOTOXICITY; RAF; INHIBITOR; CARCINOMA; KINASE; GROWTH;
D O I
10.3390/molecules201219809
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1H-Benzo[f]indazole-4,9-dione derivatives conjugated with C-protected amino acids (glycine, l-alanine, l-phenylalanine and l-glutamic acid) 6a-l were prepared by chemically modifying the prenyl substituent of 3-methyl-7-(4-methylpent-3-enyl)-1H-benzo[f]indazole-4,9-dione 2 through epoxidation, degradative oxidation, oxidation and N-acyl condensation reactions. The chemical structures of the synthesized compounds were elucidated by analyzing their IR, H-1-NMR and C-13-NMR spectral data together with elemental analysis for carbon, hydrogen and nitrogen. The preliminary in vitro antiproliferative activity of the synthesized derivatives was evaluated on KATO-III and MCF-7 cell lines using a cell proliferation assay. The majority of the derivatives exhibited significant antiproliferative activity with IC50 values ranging from 25.5 to 432.5 M. These results suggest that 1H-benzo[f]indazole-4,9-dione derivatives are promising molecules to be researched for developing new anticancer agents.
引用
收藏
页码:21924 / 21938
页数:15
相关论文
共 36 条
[1]  
[Anonymous], 2005, AMST DENS FUNCT ADF
[2]   Self-consistent molecular Hartree-Fock-Slater calculations - I. The computational procedure [J].
Baerends, E. J. ;
Ellis, D. E. ;
Ros, P. .
CHEMICAL PHYSICS, 1973, 2 (01) :41-51
[3]  
BAERENDS EJ, 1978, INT J QUANTUM CHEM, V12, P169
[4]   SYNTHESIS OF HETEROCYCLIC QUINONES [J].
BAXTER, I ;
DAVIS, BA .
QUARTERLY REVIEWS, 1971, 25 (02) :239-+
[5]   Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines [J].
Benites, Julio ;
Valderrama, Jaime A. ;
Rivera, Felipe ;
Rojo, Leonel ;
Campos, Nair ;
Pedro, Madalena ;
Jose Nascimento, Maria Saeo .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (02) :862-868
[6]   3-DIMENSIONAL NUMERICAL-INTEGRATION FOR ELECTRONIC-STRUCTURE CALCULATIONS [J].
BOERRIGTER, PM ;
VELDE, GT ;
BAERENDS, EJ .
INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 1988, 33 (02) :87-113
[7]  
BROCKMANN H, 1965, TETRAHEDRON LETT, P4593
[8]   REDOX AND ADDITION CHEMISTRY OF QUINOID COMPOUNDS AND ITS BIOLOGICAL IMPLICATIONS [J].
BRUNMARK, A ;
CADENAS, E .
FREE RADICAL BIOLOGY AND MEDICINE, 1989, 7 (04) :435-477
[9]   Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90 [J].
Buchstaller, Hans-Peter ;
Eggenweiler, Hans-Michael ;
Sirrenberg, Christian ;
Graedler, Ulrich ;
Musil, Djordje ;
Hoppe, Edmund ;
Zimmermann, Astrid ;
Schwartz, Harry ;
Maerz, Joachim ;
Bomke, Joerg ;
Wegener, Ansgar ;
Wolf, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) :4396-4403
[10]   Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors [J].
Clark, JW ;
Eder, JP ;
Ryan, D ;
Lathia, C ;
Lenz, HJ .
CLINICAL CANCER RESEARCH, 2005, 11 (15) :5472-5480